Advertisement

General Psychiatry

Novel Agent Promising in Schizophrenia

Non-D2-receptor-binding agent resulted in reductions in psychosis, negative symptoms Treatment with an investigational non-D2-receptor-binding agent led to significant reductions in psychosis and negative symptoms in...

Read More

Advertisement

For latest news and updates
Email-id is invalid

Meeting Coverage